Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome

被引：0
|
作者：
Gauchan, Dron [1 ]
Shaaban, Hamid [1 ]
Gedeon, David [2 ]
Maroules, Michael [1 ]
机构：
[1] Seton Hall Univ, Sch Hlth & Med Sci, St Josephs Reg Med Ctr, Dept Hematol Oncol, Paterson, NJ 07079 USA
[2] New York Med Coll, Valhalla, NY 10595 USA
来源：
ANNALS OF HEMATOLOGY | 2014年 / 93卷 / 10期
关键词：
EFFICACY; SAFETY;
D O I：
10.1007/s00277-014-2032-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1777 / 1778
页数：2
相关论文
共 50 条
  • [31] Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial
    Oliva, E. N.
    Santini, V.
    Zini, G.
    Palumbo, G. A.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M. T.
    Molteni, A.
    Sanpaolo, G.
    Liberati, M.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M. A. Aloe
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Di Raimondo, F.
    Leoni, P.
    Alimena, G.
    Latagliata, R.
    Nobile, F.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [32] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
    Oliva, E.
    Santini, V.
    Zini, G.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M.
    Molteni, A.
    Sanpaolo, G.
    Liberati, A.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M.
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Raimondo, F.
    Leoni, P.
    Alimena, G.
    Fioritoni, G.
    Latagliata, R.
    Nobile, F.
    [J]. HAEMATOLOGICA, 2013, 98 : 456 - 456
  • [33] LOW DOSES OF ELTROMBOPAG FOR THE TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA
    Jimenez Barcenas, R.
    Gallo Cavero, D.
    Rodriguez Martorell, F. J.
    Nunez Vazquez, R.
    Perez Garrido, R.
    Perez-Simon, Jose Antonio
    [J]. HAEMATOLOGICA, 2015, 100 : 226 - 226
  • [34] Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
    Lambert, Michele P.
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2016, 7 : 39 - 43
  • [35] ELTROMBOPAG FOR LOW TO INTERMEDIATE-2 RISK MYELODYSPLASTIC SYNDROME
    Townsley, D.
    Desmond, R.
    Weinstein, B.
    Parikh, A.
    Valdez, J.
    Dumitriu, B.
    Winkler, T.
    Olnes, M.
    Dunbar, C. E.
    Young, N. S.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S26 - S27
  • [36] Eltrombopag-based combination treatment for immune thrombocytopenia
    Gomez-Almaguer, David
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (10) : 309 - 317
  • [37] A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure
    Duong, Vu H.
    Al Ali, Najla
    Zhang, Ling
    Padron, Eric
    Sallman, David
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 1901 - 1907
  • [38] Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
    Bono, Elisa
    McLornan, Donal
    Travaglino, Erica
    Gandhi, Shreyans
    Galli, Anna
    Khan, Alesia Abigael
    Kulasekararaj, Austin G.
    Boveri, Emanuela
    Raj, Kavita
    Elena, Chiara
    Ireland, Robin M.
    Bianchessi, Antonio
    Jiang, Jie
    Todisco, Gabriele
    Ferretti, Virginia Valeria
    Cazzola, Mario
    Marsh, Judith C. W.
    Malcovati, Luca
    Mufti, Ghulam J.
    [J]. LEUKEMIA, 2019, 33 (10) : 2495 - 2505
  • [39] Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant
    Tian, Hong
    Kong, Danqing
    Li, Yun
    Gu, Chengyuan
    Yu, Ziqiang
    Wang, Zhaoyue
    Wu, Depei
    Yin, Jie
    [J]. PLATELETS, 2022, 33 (06) : 951 - 953
  • [40] Eltrombopag treatment for severe refractory thrombocytopenia caused by pembrolizumab
    Song, Peng
    Zhang, Li
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 121 : 4 - 6
12345